5-氟尿嘧啶与吉西他滨联合同期放疗治疗局部进展胰腺癌的临床效果

摘要
图/表
参考文献(21)
相关文章 (15)

全文: PDF (558 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨5-氟尿嘧啶与吉西他滨联合同期放疗治疗局部进展胰腺癌的临床效果。方法回顾性分析四川省简阳市人民医院2012年2月～2016年3月收治的局部进展胰腺癌患者80例的临床资料，依据治疗措施不同进行分组，治疗A组（吉他西滨治疗）30例，治疗B组（5-氟尿嘧啶、吉西他滨治疗）50例。观察两组患者治疗前后体能量表评分、疼痛指数评分、总体幸福感评估量表评分、Spitzer生活质量指数评分情况，比较两组患者临床治疗缓解率情况。结果治疗后两组体能量表评分、疼痛指数评分均显著低于治疗前，总体幸福感评估量表评分、Spitzer生活质量指数评分均显著高于治疗前，差异均有统计学意义（P ＜ 0.05）。治疗后治疗B组体能量表评分、疼痛指数评分均低于治疗A组，总体幸福感评估量表评分、Spitzer生活质量指数评分均高于治疗A组，差异均有统计学意义（P ＜ 0.05）。治疗B组缓解率显著高于治疗A组，差异有统计学意义（P ＜ 0.05）。结论 5-氟尿嘧啶与吉西他滨联合同期放疗治疗局部进展胰腺癌患者可以明显改善患者体能、生活质量，降低疼痛程度，提高总体幸福感和临床疗效，值得推广应用。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	叶世富陈炀首峰林远洪叶岭

关键词 ： 5-氟尿嘧啶, 吉西他滨, 放疗, 局部进展胰腺癌

Abstract：Objective To investigate the clinical effect of 5-Fluorouracil and Gemcitabine combined with concurrent radiotherapy in the treatment of locally advanced pancreatic carcinoma. Methods The clinical data of 80 cases of patients with locally advanced pancreatic carcinoma admitted to Jianyang People's Hospital from February 2012 to March 2016 was analyzed retrospectively, they were divided into two groups by different treatment methods, treatment group A (Gemcitabine treatment) had 30 cases, treatment group B (5-Fluorouracil, Gemcitabine treatment) had 50 cases. The physical inventory score, pain index score, general well-being assessment scale, Spitzer life quality index score of two groups before and after treatment were observed, the remission rate of clinical treatment between the two groups was compared. Results The physical inventory score, pain index score of two groups after treatment were lower than those before treatment, the general well-being assessment scale score, Spitzer quality of life index score were higher than those before treatment, the differences were all statistically significant (P ＜ 0.05). After treatment, the physical inventory score and pain index score of treatment group B were lower than those of treatment group A, the general well-being assessment scale score and Spitzer quality of life index score were higher than those of treatment group A, the differences were all statistically significant (P ＜ 0.05). The remission rate of treatment group B was higher than that of treatment group A, the difference was statistically significant (P ＜ 0.05). Conclusion 5-Fluorouracil and Gemcitabine combined with concurrent radiotherapy in the treatment of locally advanced pancreatic carcinoma can improve the patients' physical inventory, quality of life, decrease the pain degree, increase general well-being assessment and clinical effect, which is worthy of promotion and application.

Key words： 5-Fluorouracil Gemcitabine Radiotherapy Locally advanced pancreatic carcinoma

引用本文:

叶世富陈炀首峰林远洪叶岭. 5-氟尿嘧啶与吉西他滨联合同期放疗治疗局部进展胰腺癌的临床效果[J]. 中国医药导报, 2017, 14(14): 84-87.
YE Shifu CHEN Yang SHOU Feng LIN Yuanhong YE Ling. Clinical effect of 5-Fluorouracil and Gemcitabine combined with concurrent radiotherapy in the treatment of locally advanced pancreatic carcinoma. 中国医药导报, 2017, 14(14): 84-87.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2017/V14/I14/84

[1] 梅林.替吉奥联合吉西他滨治疗晚期胰腺癌疗效观察[J].中国预防医学杂志，2016，17（11）：863-865.
[2] Tempero MA，Arnoletti JP，Behrman SW，et al. Pan-creatic adenocarcinoma，version 2.2012：featured updates to the NCCN guide-lines [J]. J Natl Compr Canc Netw，2012，10（6）：703-713.
[3] 李小明，胡爱虹，张帆.吉西他滨联合替吉奥治疗晚期转移性胰腺癌的临床疗效和安全性评价[J].中国临床药理学杂志，2015，31（4）：261-263.
[4] 中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南（2014）[J].中国实用外科杂志，2014，34（1）：1011-1017.
[5] 美国东部肿瘤协作组.体能状态评分ECOG评分法[J].中华普通外科学文献：电子版，2012，6（6）：556.
[6] Woodforde JM，Merskey H. Some relationships between subjective measures of pain [J]. J Psychosom Res，1972，16（3）：173-178.
[7] Jensen MP，Chen C，Brugger AM. Interpretation of visual analog scale ratings and change scores：a reanalysis of two clinical trials of postoperative pain [J]. J Pain，2003，4（7）：407-414.
[8] Gallagher EJ，Liebman M，Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale [J]. Ann Emerg Med，2001，38（6）：633-638.
[9] 邢占军.主观幸福感测量研究[J].心理科学，2002，25（3）：337-338.
[10] Young SL，Ensing DS. Exploring the perspective of people with psychiatric disabilities [J]. Psychiatr Rehabilitation J，1999，22（3）：219-231.
[11] 高谦，洪冰，刘少雄，等.Spitzer生活质量指数测量脑卒中患者的效度研究[J].中国康复医学杂志，1995，10（2）：49-51.
[12] Spitzer WO，Dobson AJ，Hall J，et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians [J]. J Chron Dis，1981，34（12）：585-597.
[13] 孙燕，周际昌.临床肿瘤内科手册[M].3版.北京：人民卫生出版社，1996：30.
[14] 黄金昶.胰腺癌疗效评价标准[C].中华中医药学会2012年中医药防治肿瘤学术年会，2013.
[15] 柯珂，余云熹.吉西他滨联合奥沙利铂或5氟尿嘧啶治疗晚期胰腺癌的临床应用[J].中国肿瘤临床与康复，2016， 23（6）：705-707.
[16] Gourgou-Bourgade S，Bascoul-Mollevi C，Desseigne F，et al. Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer：results from the PRODIGE 4/ACCORD 11 randomized trial [J]. J Clin Oncol，2013，31（1）：23-29.
[17] 朱琳，黄英.吉西他滨联合替吉奥化疗在胰腺癌根治术后患者中的应用[J].中国肿瘤临床与康复，2016，23（11）：1319-1321.
[18] Oxberry S，Middleton V，Bennett M. What does a good quality of life for cancer patients mean on a numerical rating scale [J]. J Clin Oncol，2005，17（2）：129.
[19] 龚虹云，宋启斌，李祥攀，等.吉西他滨联合调强放疗治疗局部晚期胰腺癌21例[J].肿瘤学杂志，2016，22（1）：76-78.
[20] 尹文琤，马力文.靶向药物在进展期胰腺癌中的研究进展[J].癌症进展，2015，13（6）：604-608，636.
[21] Huguet F，André T，Hammel P，et al. Impact of chemora-diotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase Ⅱ and Ⅲ studies [J]. J Clin Oncol，2007，25（3）：326-331.